Allowing people to mix COVID-19 vaccines could cut into Pfizer and Moderna’s revenue next year

Expect to see data this month from several clinical trials that are trying to establish if “mixing and matching” different COVID-19 vaccines is safe and effective or if it’s better to get the same booster as the one used in the primary series of shots.
Stock Quote API & Stock News API supplied by www.cloudquote.io
Quotes delayed at least 20 minutes.
By accessing this page, you agree to the following
Privacy Policy and Terms and Conditions.